Latest news
McDermott Will & Schulte advises Ares and DaVita on investment in Elara Caring - McDermott Will & SchulteMcDermott Will & Schulte · Thu, 06 Aug 2026 07:00:00 GMTNIPRO Launches Expanded Hemodialysis with ELISIO™-HX to U.S. Providers Following FDA Clearance - Macau BusinessMacau Business · Wed, 05 Aug 2026 07:00:00 GMTDaVita Expands Access to Advanced Middle Molecule Clearance - DaVita NewsroomDaVita Newsroom · Wed, 05 Aug 2026 06:53:00 GMTPharmac Expands Access to Type 2 Diabetes Medicines - DevdiscourseDevdiscourse · Wed, 05 Aug 2026 06:47:44 GMTDaVita Q2 Earnings Call Highlights - TradingViewTradingView · Wed, 05 Aug 2026 06:03:51 GMT[DVA Q2 2026 Earnings Call] DaVita to Roll Out Expanded Dialyzers Across Network, Lifts Volume Target to 50-75 Basis Points - finance.biggo.comfinance.biggo.com · Tue, 04 Aug 2026 23:45:00 GMTDaVita Inc. 2026: Revenue $3.55B, EPS $4.02— 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 21:11:01 GMTHere's Why You Should Retain DaVita Stock in Your Portfolio for Now - TradingViewTradingView · Wed, 29 Jul 2026 15:03:00 GMT